Hiprex vs. Fosfomycin
See how Hiprex and Fosfomycin compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Hiprex is used long-term to prevent recurrent UTIs, while Fosfomycin treats an active uncomplicated UTI with a single dose.
Hiprex requires twice-daily dosing indefinitely, whereas Fosfomycin is taken once and the treatment is done.
Fosfomycin causes more gastrointestinal side effects like diarrhea and headache, while Hiprex's side effects are milder and less frequent.
Hiprex vs. Fosfomycin Drug Summary
Hiprex
Hiprex (methenamine hippurate) is a urinary antiseptic used to prevent recurrent UTIs rather than treat an active infection. It works by releasing formaldehyde in acidic urine, which kills bacteria nonspecifically. It's taken as a 1 g tablet twice daily, often for months or years.
Fosfomycin
Fosfomycin (fosfomycin tromethamine) is a phosphonic acid antibacterial approved to treat active, uncomplicated UTIs in women. It's taken as a single 3 g dose dissolved in water, with no multi-day course needed. It's sometimes used off-label in repeated doses for complicated UTIs or chronic prostatitis.
Hiprex vs. Fosfomycin Side Effects
Hiprex
Fosfomycin
Hiprex vs. Fosfomycin Dosage
Hiprex
Fosfomycin
| STAGE | DOSE | WHEN |
| Starting dose | 1 g twice daily | At the start |
| Maximum dose | 1 g twice daily | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 3 g single dose | At the start |
| Maximum dose | 3 g single dose | Same as starting |
| Dose changes | None | Fixed dose |
Hiprex
| STAGE | DOSE | WHEN |
| Starting dose | 1 g twice daily | At the start |
| Maximum dose | 1 g twice daily | Same as starting |
| Dose changes | None | Fixed dose |
Fosfomycin
| STAGE | DOSE | WHEN |
| Starting dose | 3 g single dose | At the start |
| Maximum dose | 3 g single dose | Same as starting |
| Dose changes | None | Fixed dose |
Hiprex vs. Fosfomycin Indications
Hiprex
Hiprex is approved only for preventing frequent, recurrent UTIs as part of long-term suppressive therapy, not for treating an active infection. It needs acidic urine to work and is not effective against Proteus or other urease-producing bacteria. It's typically prescribed for people with documented recurrent UTIs.
Prevents frequent recurrent UTIs
Requires acidic urine to activate
Not effective against Proteus or urease-producing bacteria
Not for treating an active infection
Used for long-term suppressive therapy
Fosfomycin
Fosfomycin is approved to treat acute, uncomplicated UTIs in women caused by susceptible E. coli or E. faecalis. It's not approved for pyelonephritis, complicated UTI, or use in men or children under 12. Off-label, it's sometimes used in multi-dose regimens for complicated UTIs or chronic prostatitis.
Treats active uncomplicated UTI (cystitis)
Approved only for women
Not approved for pyelonephritis or complicated UTI
Off-label use for prostatitis (multi-dose)
Not approved for children 12 and under
Hiprex vs. Fosfomycin Pros and Cons
Hiprex
Hiprex offers a long-term option for preventing UTIs in people with frequent recurrences, working through a non-antibiotic mechanism that avoids resistance concerns. It requires consistent twice-daily dosing and acidic urine to stay effective, and it does not treat infections that are already underway.
Pros
Long-term prevention rather than short-term treatment
Low reported rate of side effects
Non-antibiotic mechanism avoids resistance concerns
Decades-long track record of use
Cons
Requires twice-daily dosing indefinitely
Ineffective in alkaline urine or against Proteus
Contraindicated in kidney or severe liver impairment
Not a treatment for active infections
Fosfomycin
Fosfomycin treats an active uncomplicated UTI with a single oral dose, which can improve adherence compared with multi-day antibiotic courses. It's approved specifically for women with uncomplicated cystitis, and it causes gastrointestinal side effects somewhat more often than milder alternatives.
Pros
Single-dose treatment completes therapy in one day
Approved for treating active infection, not just prevention
Effective against E. coli and E. faecalis in one dose
No need for ongoing daily dosing
Cons
Higher rates of diarrhea and headache
Not approved for men or children 12 and under
Not approved for pyelonephritis or complicated UTI
Repeated dosing hasn't shown added benefit, only more side effects
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.